We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its COVID-19 vaccine, which was authorized in the United States in December 2020. Moderna had 44 mRNA development programs as of ... Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its COVID-19 vaccine, which was authorized in the United States in December 2020. Moderna had 44 mRNA development programs as of early 2022, with 25 of these in clinical trials. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases. Show more
Apple (NASDAQ:AAPL) – Apple will obtain an observer role on the OpenAI board as part of an AI agreement, with Phil Schiller chosen for the position. This arrangement will allow Schiller to...
Period † | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.09 | 0.0743740186761 | 121.01 | 124.055 | 115.47 | 2341994 | 120.36795769 | CS |
4 | 4.05 | 3.4600598035 | 117.05 | 129.3642 | 114.02 | 2807759 | 119.87441564 | CS |
12 | -3.96 | -3.16648008956 | 125.06 | 170.47 | 114.02 | 3864668 | 136.40167124 | CS |
26 | 17.6 | 17.0048309179 | 103.5 | 170.47 | 84.06 | 3848267 | 117.77496355 | CS |
52 | -0.77 | -0.631820792648 | 121.87 | 170.47 | 62.55 | 4211273 | 105.32481257 | CS |
156 | -230.9 | -65.5965909091 | 352 | 497.17 | 62.55 | 6286199 | 212.74588716 | CS |
260 | 107.51 | 791.096394408 | 13.59 | 497.17 | 11.54 | 8933785 | 148.2167906 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions